Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC
Clinical trial NCT04455594 · UNKNOWN
Trial details
- NCT number
- NCT04455594
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-01-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.